Review
BibTex RIS Cite

Year 2020, Volume: 5 Issue: 2, 147 - 151, 30.06.2020

Funda Sofulu , Berna Özgürsoy Uran , Elif Ünsal Avdal , Yasemin Tokem

Abstract

References

  • Aihong, W., Weibo, Z., Zhangrong, X. & Jianwen, G. (2020). Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract., 162,108118.
  • Bansal, M. (2020). Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 247-250.
  • Centers for Disease Control and Prevention (CDC). (2019). Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVIDNET, 14 States, March 1–30, 2020. Retrieved April 17, 2020, from https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e3.htm?s_cid=mm6915e3_w#T1_down/index.html.
  • Centers for Disease Control and Prevention. (2019). National Center for Immunization and Respiratory Diseases, Division of Viral Diseases. Coronavirus disease (COVID-19). Are you at higher risk for severe illness? Retrieved April 15, 2020. from https://www.cdc.gov/ coronavırus/2019-ncov/need-extra-precautıons/groups-at-hıgherrısk. html.
  • Cheng, V.C.C, Lau, S.K.P, Woo, P.C.Y, Yuen, K.Y. (2007). Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev., 20(4),660-694. doi:10.1128/CMR.00023-07
  • Huang C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X. et al.(2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506
  • Hussain, A., Bhowmik, B., Vale, M.N.C. (2020). COVID-19 and Diabetes: Knowledge in Progress. Diabetes Res Clin Pract., 9, 108142. doi:10.1016/j.diabres.2020.108142
  • Jonathan, P.S., Samkeliso, B., Tess H., Cook, D.G & Critchley J. (2016). Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol., 4(2),148–158.
  • Liang, T. (2020). Handbook of COVID-19 Prevention and Treatment. Retrieved April 15, 2020, from https://www.researchgate.net/ publication/339998871_Handbook_of_COVID-19_Prevention_ and_Treatment.
  • Ma, J., Hu, F., Sun, H.M., Chen, J., Ding, X.B., Li, J. (2019). Nursing experience of treating a critical ill patient with novel coronavirus (2019-nCoV) infected pneumonia by using. ECMO. J New Med, 30,74-77.
  • Madjid, M., Safavi-Naeini, P., Solomon, S.D., Vardeny, O. (2020). Potential Effects of Coronaviruses on the Cardiovascular System A Review. JAMA Cardiol. doi:10.1001/jamacardio.2020.1286
  • McDonald, H.I., Nitsch, D., Millett, E.R.C., Sinclair, A., Thomas, S.L.(2014). New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records. Diabet Med, 31(5), 606–614.
  • Odegaard, J.I. & Chawla, A. (2012). Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harbor Perspectives in Medicine, 2, a007724.
  • Rodriguez-Morales, A.J., Cardona-Ospina, J.A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., HolguinRivera, Y., Escalera-Antezana, J.P., et al. (2020). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease, 10, 16-23.
  • T.C. Sağlık Bakanlığı. (2020). COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi, https://covid19bilgi.saglik.gov.tr/tr/. Erişim Tarihi: 30 Nisan 2020.
  • T.C. Sağlık Bakanlığı. (2020). Kanser Hastaları Tanı ve Tedavi Merkezlerinde Alınması Gereken Enfeksiyon Kontrol Önlemleri, https://covid19bilgi.saglik.gov.tr/. Erişim Tarihi: 30 Nisan 2020.
  • Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al.(2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama, 323, 1061–1069.
  • Williams, R., Karuranga, S., Malanda, B., Saeedi, P., Basit, A., Besançon, S. (2020). Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 9th edition. Diabetes Res Clin Pract., 162, 108072. doi: 10.1016/j. diabres.2020.108072.
  • World Health Organization. (2019). Coronavirus Disease 2019 (Covid-19) Technical Guidance, Retrieved April 15, 2020, from https://www. who.int/health-topics/coronavirus#tab=tab_1.
  • World Health Organization. (2019). Naming the coronavirus disease (COVID-19) and the virus that causes it. Retrieved April 07, 2020, from https://www.who. int/emergencies/diseases/novelcoronavirus- 2019/technical-guidance/naming-the-coronavirusdisease-( covid-2019)-and-the-virusthat-causes-it.
  • World Health Organization. (2020). Clinical management of severe acute respiratory infection when COVID-19 is suspected Interim guidance. Retrieved April 15, 2020, from https://www.who. int/publications-detail/clinicalmanagement-of-severe-acuterespiratory- infection-when-novel-coronavirus-(ncov)- infection-issuspected].
  • World Health Organization. (2020). Clinical management of COVID-19. Retrieved April 18, 2020, from https://www.who.int/publications/i/ item/clinical-management-of-covid-19.
  • Wu, Z. & McGoogan, J.M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease Control and prevention. JAMA Med Assoc., 323(13), 1239-1242. doi:10.1001/jama.2020.2648
  • Yang, H., Zhenga, Y,. , Goua, X,. , Pua, K., Chena, Z., Guoa,,Q., Jia, R., Wangb, H., Wanga, Y., Zhou, Y.(2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases, 94, 91–95
  • Yu, C.M., Wong, R.S.M., Wu, E.B., Kong S.L., Wong J., Yip G., et al. (2006). Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J., 82(964), 140-144. doi:10.1136/pgmj.2005.037515
  • Zhou, J. & Tan, J. (2020). Diabetes patients with COVID-19 need better care. Metabolism. 107, 154216, doi: 10.1016/j.metabol.2020.154216
  • Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L. et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270-27

COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi

Year 2020, Volume: 5 Issue: 2, 147 - 151, 30.06.2020

Funda Sofulu , Berna Özgürsoy Uran , Elif Ünsal Avdal , Yasemin Tokem

Abstract

Özet


Kronik hastalıkların bağışıklık sistemi üzerinde çeşitli etkileri vardır ve bir kişiyi COVID-19 enfeksiyonuna karşı daha yatkın hale getirir. COVID-19 pandemisi sırasında, kronik hastalıkları olan kişiler yakından izlenmelidir. COVID-19 yeni viral enfeksiyonu için tam bir tedavi yöntemi yoktur. Tedavide çeşitli antiviral ilaçlar kullanılmaktadır. COVID-19 enfeksiyonunun risk faktörleri henüz tam olarak bilinmemektedir. Ancak, kronik hastalıkları olan kişilerin (ciddi kalp rahatsızlıkları, kronik akciğer hastalığı, diyabet, kronik böbrek hastalıkları ve karaciğer hastalığı gibi) COVID-19 enfeksiyonu açısından daha fazla risk altındadır. Kronik hastalıkları olan hastalar tedavi planlarına uygun olarak bakım ve ilaçlarını almaya devam etmelidirler. COVID-19 salgını sırasında, hemşirelerin kronik hastalıkları olan kişilere, klinik semptomlarındaki değişikliklerin farkında olmaları ve koruyucu önlemlere konusunda (el hijyeni, evde daha uzun süre kalmak, sosyal mesafeyi korumak gibi) eğitim vermeleri oldukça önemlidir.


Anahtar Kelimeler: COVID-19, pandemi, kronik hastalıklar, hemşirelik.


Abstract


Chronic diseases seem to have various effects on the immune system and make a person more susceptible to COVID-19 infection. During the COVID-19 pandemic, people with chronic diseases should be closely monitored. There is no complete cure method for COVID-19 new viral infection. Various antiviral drugs are used in the treatment. The risk factors of COVID-19 infection are not yet not exactly known. However, people with chronic diseases (such as serious heart conditions, chronic lung disease, diabetes, chronic kidney diseases, and liver disease) are at higher risk for COVID-19 infection. Patients with chronic diseases should continue taking their care and medications according to their treatment plan. During COVID-19 pandemic, it is important that nurses have to educate the patients with chronic diseases be aware of any changes in the clinical symptoms of their chronic diseases and on protective measures (such as hand washing, stay at home, social distance).


Keywords: COVID-19, pandemic, chronic diseases, nursing.

Keywords

COVID-19 pandemi kronik hastalıklar hemşirelik

References

  • Aihong, W., Weibo, Z., Zhangrong, X. & Jianwen, G. (2020). Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed. Diabetes Res Clin Pract., 162,108118.
  • Bansal, M. (2020). Cardiovascular disease and COVID-19. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 14, 247-250.
  • Centers for Disease Control and Prevention (CDC). (2019). Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVIDNET, 14 States, March 1–30, 2020. Retrieved April 17, 2020, from https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e3.htm?s_cid=mm6915e3_w#T1_down/index.html.
  • Centers for Disease Control and Prevention. (2019). National Center for Immunization and Respiratory Diseases, Division of Viral Diseases. Coronavirus disease (COVID-19). Are you at higher risk for severe illness? Retrieved April 15, 2020. from https://www.cdc.gov/ coronavırus/2019-ncov/need-extra-precautıons/groups-at-hıgherrısk. html.
  • Cheng, V.C.C, Lau, S.K.P, Woo, P.C.Y, Yuen, K.Y. (2007). Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev., 20(4),660-694. doi:10.1128/CMR.00023-07
  • Huang C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X. et al.(2020). Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 395(10223):497-506
  • Hussain, A., Bhowmik, B., Vale, M.N.C. (2020). COVID-19 and Diabetes: Knowledge in Progress. Diabetes Res Clin Pract., 9, 108142. doi:10.1016/j.diabres.2020.108142
  • Jonathan, P.S., Samkeliso, B., Tess H., Cook, D.G & Critchley J. (2016). Diabetes and infection: assessing the association with glycaemic control in population-based studies. Lancet Diabetes Endocrinol., 4(2),148–158.
  • Liang, T. (2020). Handbook of COVID-19 Prevention and Treatment. Retrieved April 15, 2020, from https://www.researchgate.net/ publication/339998871_Handbook_of_COVID-19_Prevention_ and_Treatment.
  • Ma, J., Hu, F., Sun, H.M., Chen, J., Ding, X.B., Li, J. (2019). Nursing experience of treating a critical ill patient with novel coronavirus (2019-nCoV) infected pneumonia by using. ECMO. J New Med, 30,74-77.
  • Madjid, M., Safavi-Naeini, P., Solomon, S.D., Vardeny, O. (2020). Potential Effects of Coronaviruses on the Cardiovascular System A Review. JAMA Cardiol. doi:10.1001/jamacardio.2020.1286
  • McDonald, H.I., Nitsch, D., Millett, E.R.C., Sinclair, A., Thomas, S.L.(2014). New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records. Diabet Med, 31(5), 606–614.
  • Odegaard, J.I. & Chawla, A. (2012). Connecting type 1 and type 2 diabetes through innate immunity. Cold Spring Harbor Perspectives in Medicine, 2, a007724.
  • Rodriguez-Morales, A.J., Cardona-Ospina, J.A., Gutiérrez-Ocampo, E., Villamizar-Peña, R., HolguinRivera, Y., Escalera-Antezana, J.P., et al. (2020). Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis. Travel Medicine and Infectious Disease, 10, 16-23.
  • T.C. Sağlık Bakanlığı. (2020). COVID-19 (SARS-CoV-2 Enfeksiyonu) Rehberi, https://covid19bilgi.saglik.gov.tr/tr/. Erişim Tarihi: 30 Nisan 2020.
  • T.C. Sağlık Bakanlığı. (2020). Kanser Hastaları Tanı ve Tedavi Merkezlerinde Alınması Gereken Enfeksiyon Kontrol Önlemleri, https://covid19bilgi.saglik.gov.tr/. Erişim Tarihi: 30 Nisan 2020.
  • Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., et al.(2020). Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama, 323, 1061–1069.
  • Williams, R., Karuranga, S., Malanda, B., Saeedi, P., Basit, A., Besançon, S. (2020). Global and regional estimates and projections of diabetes-related health expenditure: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract. 9th edition. Diabetes Res Clin Pract., 162, 108072. doi: 10.1016/j. diabres.2020.108072.
  • World Health Organization. (2019). Coronavirus Disease 2019 (Covid-19) Technical Guidance, Retrieved April 15, 2020, from https://www. who.int/health-topics/coronavirus#tab=tab_1.
  • World Health Organization. (2019). Naming the coronavirus disease (COVID-19) and the virus that causes it. Retrieved April 07, 2020, from https://www.who. int/emergencies/diseases/novelcoronavirus- 2019/technical-guidance/naming-the-coronavirusdisease-( covid-2019)-and-the-virusthat-causes-it.
  • World Health Organization. (2020). Clinical management of severe acute respiratory infection when COVID-19 is suspected Interim guidance. Retrieved April 15, 2020, from https://www.who. int/publications-detail/clinicalmanagement-of-severe-acuterespiratory- infection-when-novel-coronavirus-(ncov)- infection-issuspected].
  • World Health Organization. (2020). Clinical management of COVID-19. Retrieved April 18, 2020, from https://www.who.int/publications/i/ item/clinical-management-of-covid-19.
  • Wu, Z. & McGoogan, J.M. (2020). Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese center for disease Control and prevention. JAMA Med Assoc., 323(13), 1239-1242. doi:10.1001/jama.2020.2648
  • Yang, H., Zhenga, Y,. , Goua, X,. , Pua, K., Chena, Z., Guoa,,Q., Jia, R., Wangb, H., Wanga, Y., Zhou, Y.(2020). Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. International Journal of Infectious Diseases, 94, 91–95
  • Yu, C.M., Wong, R.S.M., Wu, E.B., Kong S.L., Wong J., Yip G., et al. (2006). Cardiovascular complications of severe acute respiratory syndrome. Postgrad Med J., 82(964), 140-144. doi:10.1136/pgmj.2005.037515
  • Zhou, J. & Tan, J. (2020). Diabetes patients with COVID-19 need better care. Metabolism. 107, 154216, doi: 10.1016/j.metabol.2020.154216
  • Zhou, P., Yang, X.L., Wang, X.G., Hu, B., Zhang, L., Zhang, W., Si, H.R., Zhu, Y., Li, B., Huang, C.L. et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature, 579(7798), 270-27
There are 27 citations in total.

Details

Primary Language Turkish
Subjects Health Care Administration
Journal Section Derlemeler
Authors

Funda Sofulu 0000-0002-1252-8158

Berna Özgürsoy Uran 0000-0002-4096-4619

Elif Ünsal Avdal 0000-0001-6888-0882

Yasemin Tokem 0000-0001-9140-2846

Publication Date June 30, 2020
Submission Date May 17, 2020
Published in Issue Year 2020 Volume: 5 Issue: 2

Cite

APA Sofulu, F., Özgürsoy Uran, B., Ünsal Avdal, E., Tokem, Y. (2020). COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, 5(2), 147-151.
AMA Sofulu F, Özgürsoy Uran B, Ünsal Avdal E, Tokem Y. COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi. İKÇÜSBFD. June 2020;5(2):147-151.
Chicago Sofulu, Funda, Berna Özgürsoy Uran, Elif Ünsal Avdal, and Yasemin Tokem. “COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 5, no. 2 (June 2020): 147-51.
EndNote Sofulu F, Özgürsoy Uran B, Ünsal Avdal E, Tokem Y (June 1, 2020) COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 5 2 147–151.
IEEE F. Sofulu, B. Özgürsoy Uran, E. Ünsal Avdal, and Y. Tokem, “COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi”, İKÇÜSBFD, vol. 5, no. 2, pp. 147–151, 2020.
ISNAD Sofulu, Funda et al. “COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi 5/2 (June 2020), 147-151.
JAMA Sofulu F, Özgürsoy Uran B, Ünsal Avdal E, Tokem Y. COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi. İKÇÜSBFD. 2020;5:147–151.
MLA Sofulu, Funda et al. “COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi”. İzmir Katip Çelebi Üniversitesi Sağlık Bilimleri Fakültesi Dergisi, vol. 5, no. 2, 2020, pp. 147-51.
Vancouver Sofulu F, Özgürsoy Uran B, Ünsal Avdal E, Tokem Y. COVID-19 Salgınında Kronik Hastalıklarda Hemşirelik Yönetimi. İKÇÜSBFD. 2020;5(2):147-51.
 Download Cover Image



Licensed under a Creative Commons Attribution 4.0 International License.